profit from every €100 of sales.
€0€100
Eurofins Scientific
€87.98+0.02% today
+42.8% since Dec 23, 25
1-year low €57.541-year high €89.04
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay €31.69 for every €1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Eurofins Scientific sold, what it kept, and what it did with the cash.
Sales went from €6.71 billion in 2022 to €7.30 billion in 2025, with €475 million of profit last year.
SalesProfit
Eurofins Scientific handed back more cash to shareholders than it generated last year.
Buybacks €541M
Free cash flow 2025€564M
Bought back its own shares€541M
Paid as dividends€108M
Cash vs. debt€791M vs. €4.4B
Eurofins Scientific vs. similar companies
Eurofins Scientific grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| Eurofins Scientific | 31.7× · Expensive | ||
 Thermo Fisher Scientific | 38.7× · Expensive | ||
 Danaher | 45.4× · Expensive | ||
 Waters | 140.8× · Very expensive | ||
 WuXi AppTec | 25.8× · Fair price |
AI analysis
An AI analyst reads Eurofins Scientific's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 6,712 | 6,515 | 6,951 | 7,296 | |
| 4,485 | 4,364 | 4,712 | 4,970 | |
| 783 | 547 | 726 | 818 | |
| 1,495 | 1,217 | 1,397 | 1,534 | |
| 610 | 310 | 406 | 475 | |
| 3.07 | 1.57 | 2.09 | 2.55 | |
| 66.8% | 67.0% | 67.8% | 68.1% | |
| 11.7% | 8.4% | 10.4% | 11.2% | |
| 9.1% | 4.8% | 5.8% | 6.5% |
Balance sheet
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 10,084 | 10,889 | 10,888 | 10,985 |
| Cash | 487 | 1,221 | 614 | 791 |
| Total debt | 3,326 | 3,927 | 3,610 | 4,432 |
| Total liabilities | 5,233 | 5,751 | 5,504 | 6,409 |
| 4,782 | 5,078 | 5,339 | 4,543 | |
| 199 | 198 | 195 | 187 | |
| 8.2% | 4.6% | 5.9% | 6.8% | |
| 12.8% | 6.1% | 7.6% | 10.5% |
Cash flow
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1,136 | 1,018 | 1,319 | 1,399 | |
| 660 | 550 | 528 | 835 | |
| 476 | 468 | 791 | 564 | |
| Dividends paid | 192 | 192 | 96 | 108 |
| 16 | 56 | 272 | 541 | |
| 136 | 138 | 138 | 138 |
Valuation
- 31.7×
- –
- –
- 2.5×
- 2.1×
- 26.7×
- 12.2×
- 3.7%
- 3.2%
- 0.7%
Profitability
- 68.1%
- 11.2%
- 6.5%
- –
- 6.8%
- 6.4%
- –
- –
- –
- –
Growth
- +2.8%
- −6.0%
- –
- –
- −2.1%
Financial health
- 2.5×
- 0.98
- –
- 5.2×
- 1.09
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 46%of 963
Top 47%of 894
Bottom 42%of 632
Bottom 23%of 908
Top 31%of 991
0.7%of the share price, paid each year
On $1,000 invested$7a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
22.7% of its profit
Room to growStretchedMore than it earns: 19.1%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
43No pass
Benjamin Graham
42No pass
Philip Fisher
43No pass
Peter Lynch
20No pass
Joel Greenblatt
17No pass
Charlie Munger
33No pass
Terry Smith
37No pass
Questions about Eurofins Scientific
Is Eurofins Scientific a good stock to buy?
A business with weak numbers, but the price is high. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Eurofins Scientific AI analysis
What does Eurofins Scientific do?
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It is in Diagnostics & Research, based in Luxembourg, Luxembourg, with 65,694 employees.
Does Eurofins Scientific pay a dividend?
Yes. At today's price the dividend is 0.7% a year, about 23% of its yearly profit. In 2025 it paid out €108 million in dividends.
Is Eurofins Scientific stock halal?
Yes. Eurofins Scientific passes our halal screen: its business is permitted and its debt is 29% of its market value, under the 30% limit. How we check
Who are Eurofins Scientific's competitors?
The largest listed companies in the same industry are Thermo Fisher Scientific, Danaher, Waters and WuXi AppTec. The peers table on this page compares their profit, growth and price with Eurofins Scientific's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.